Quest Diagnostics Inc  

(Public, NYSE:DGX)   Watch this stock  
Find more results for DGX
+1.70 (1.78%)
Feb 24 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 95.49 - 97.35
52 week 66.51 - 97.35
Open 95.72
Vol / Avg. 807,147.00/935,688.00
Mkt cap 13.73B
P/E 21.43
Div/yield 0.45/1.85
EPS 4.54
Shares 137.50M
Beta 0.68
Inst. own 93%
Jan 26, 2017
Q4 2016 Quest Diagnostics Inc Earnings Release
Jan 26, 2017
Q4 2016 Quest Diagnostics Inc Earnings Call
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '16) 2016
Net profit margin 8.97% 9.26%
Operating margin 14.83% 16.99%
EBITD margin - 20.13%
Return on average assets 6.61% 6.94%
Return on average equity 13.38% 13.79%
Employees 43,000 -
CDP Score - 89 D


3 Giralda Farms
United States - Map
+1-973-5202700 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company operates through two businesses: Diagnostic Information Services and Diagnostic Solutions. The Company's Diagnostic Information Services business develops and delivers diagnostic testing information and services to patients, physicians, health plans, hospitals, accountable care organizations (ACOs), integrated delivery networks (IDNs), other commercial laboratories, employers and others. The Company's Diagnostic Solutions offers a range of solutions for insurers and healthcare providers. The Company provides risk assessment services for the life insurance industry. In addition, the Company offers healthcare organizations and clinicians' health information technology solutions and diagnostic products. ExamOne provides risk assessment services to the life insurance industry in North America. ChartMaxx is the Company's enterprise content management system for hospitals.

Officers and directors

Stephen H. Rusckowski Chairman of the Board, President, Chief Executive Officer
Age: 58
Bio & Compensation  - Reuters
Mark J. Guinan Chief Financial Officer, Senior Vice President
Age: 54
Bio & Compensation  - Reuters
Michael E. Prevoznik Senior Vice President, General Counsel
Age: 54
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Jon Roger Cohen M.D. Senior Vice President, Group Executive - Diagnostic Solutions
Age: 61
Bio & Compensation  - Reuters
Everett V. Cunningham Senior Vice President - Commercial
Age: 49
Bio & Compensation  - Reuters
James E. Davis Senior Vice President ,Group Executive - Regional Businesses
Age: 53
Bio & Compensation  - Reuters
Catherine T. Doherty Senior Vice President and Group Executive - Clinical Franchise Solutions
Age: 53
Bio & Compensation  - Reuters
Daniel C. Stanzione Ph.D. Lead Independent Director
Age: 70
Bio & Compensation  - Reuters
Jenne K. Britell Ph.D. Independent Director
Age: 73
Bio & Compensation  - Reuters
Vicky B. Gregg Independent Director
Age: 61
Bio & Compensation  - Reuters